• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare Conference

    Investing News Network
    Mar. 01, 2021 07:59PM PST
    Biotech Investing
    Bristol Myers Squibb today announced that the company will take part in a fireside chat at Barclays’ Virtual Global Healthcare Conference, which will be webcast on Tuesday, March 9, 2021. David Elkins Executive Vice President, Chief Financial Officer will answer questions about the company at 3 p.m. ET. Investors and the general public are invited to listen to a live webcast of the session at . Material related to ...

    Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Barclays' Virtual Global Healthcare Conference, which will be webcast on Tuesday, March 9, 2021. David Elkins , Executive Vice President, Chief Financial Officer will answer questions about the company at 3 p.m. ET.

    Investors and the general public are invited to listen to a live webcast of the session at https://investor.bms.com . Material related to the company's presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

    About Bristol Myers Squibb

    Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube , Facebook , and Instagram .

    CorporateFinancial-News

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005092/en/

    Bristol Myers Squibb
    Media:
    media@bms.com

    Investor Relations:
    Tim Power, 609-252-7509, timothy.power@bms.com
    Nina Goworek, 908-673-9711, nina.goworek@bms.com

    News Provided by Business Wire via QuoteMedia

    The Conversation (0)

    Latest News

    Seegnal Inc. Announces Extension of Maccabi Health Services Contract

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    Ă—